Infectious Thromboembolism related to prolonged reduced motility in ill acute patients

Abstract

Update in new clinic complications related to infectious diseases reveals emergent, at present, the thromboembolic risk. Clinicians must examine carefully thromboembolism related to prolonged reduced motility during acute invalidating infectious diseases because it represents major risk during clinical conditions involving enzimatic procoagulant activity, fibronectine production, procoagulant autoimmunitary damage. Recent experimental data show that pathogenesis of thromboembolic lesions involves clinical risk factors, vascular anatomic features and bacterial genetic properties.